CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial Post author: Post published:April 25, 2024 Post category:News Feed Post comments:0 Comments Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas. You Might Also Like Blood pressure levels impacted by chronic occupational noise exposure August 15, 2024 Novel and promising pancreatic cancer organoids for effective screening of anticancer drugs December 8, 2023 Air pollution harms mental health worse in New York’s historically redlined neighborhoods August 23, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Novel and promising pancreatic cancer organoids for effective screening of anticancer drugs December 8, 2023
Air pollution harms mental health worse in New York’s historically redlined neighborhoods August 23, 2024